Pune, July 22, 2024 (GLOBE NEWSWIRE) -- Rising focus on preventive healthcare and weight management is fuelling the growth of the global market for Weight Loss Drugs. Prevention is a relatively new focus for healthcare, resulting from the understanding that being overweight or obese brings with it health risks and maintaining a healthy weight has benefits. Obesity results in a range of health conditions including type 2 diabetes, cardiovascular diseases, and certain cancers that impose significant costs on healthcare systems.
The World Health Organization (WHO) projects that medical costs to address obesity-related diseases will reach $1.2 trillion globally per year by 2025. To offset these expenses, healthcare providers and policy-makers are more focused on prevention through programs to manage weight or treat overweight with medications.
Obesity prevention programs, public health campaigns, and government policies are increasing awareness regarding obesity as a preventable disease and reducing healthy weight rates to promote lifestyle changes amongst obese individuals in combination with drug-induced bodyweight reductions for lifelong maintenance of preventive combined programs. We have to embrace the untapped potential of technology and similar tools that are available today at our fingertips, making it almost foolproof for individuals attempting weight management. A growing number of people adopting preventive healthcare and practicing weight management is fueling the dem.